EPHA3 and glioblastoma: Previous studies have also shown high expression of EphA3 in glioblastoma and very low expression in normal brain,22 and a lack of expression on vital organs including heart, liver, kidney, and lung23 strongly suggesting that off-tumor on-target effects are unlikely.17